French Autorité de la Concurrence Fines Sanofi €40.6 Million for Denigrating Competing Generics"

Published date21 May 2013
Law FirmSkadden, Arps, Slate, Meagher & Flom LLP
Subject MatterAbuse of Dominance,Competition,Generic Drugs,Misrepresentation,Pharmaceutical Industry,Prescription Drugs

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT